Volume 22, Issue 2 pp. 113-116
Diagnostic Dilemmas

Mesothelial hyperplasia with reactive atypia: Diagnostic pitfalls and role of immunohistochemical studies—a case report

Andrea Lee M.D.

Andrea Lee M.D.

Division of Cytopathology and Cytometry, Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania

Search for more papers by this author
Zubair W. Baloch M.D., Ph.D.

Corresponding Author

Zubair W. Baloch M.D., Ph.D.

Division of Cytopathology and Cytometry, Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania

Division of Cytopathology and Cytometry, Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, 6 Founders Pavilion, 3400 Spruce St., Philadelphia, PA 19104.Search for more papers by this author
Gordon Yu M.D.

Gordon Yu M.D.

Division of Cytopathology and Cytometry, Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania

Search for more papers by this author
Prabodh K. Gupta M.D., F.I.A.C.

Prabodh K. Gupta M.D., F.I.A.C.

Division of Cytopathology and Cytometry, Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania

Search for more papers by this author

Abstract

The cytomorphologic features of highly reactive mesothelial cells can be difficult to distinguish from malignant cells. We report on an unusual case of mesothelial hyperplasia in a pericardial effusion. The specimen contained bizarre-shaped cells and large tissue fragments in a patient with a history of lung carcinoma. The atypical cells were negative for CEA and LeuM-1 and positive for cytokeratins (AE1/3) and HBME-1. Strong HBME-1 positivity supported a mesothelial origin of the atypical cells and led to the diagnosis of reactive mesothelium. While HBME-1 cannot be used as the sole marker to establish an mesothelial origin; its use in a immunohistochemistry panel may be useful in individual cases to distinguish reactive mesothelial cells from carcinoma in effusion cytology. Diagn. Cytopathol. 2000;22:113–116. © 2000 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.